Wyeth's recent announcement that chief operating officer Bernard Poussot would be taking over as CEO was abrupt and unceremonious. But the unexpected departure of Bob Essner, who will soon turn 60, signaled the end of an era at the country's fifth-largest pharmaceutical company.
Read More...
[Source: Financial news of the day - CNNMoney.com]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment